Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation

被引:443
作者
Elenbaas, B
Weinberg, RA [1 ]
机构
[1] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA
[2] MIT, Dept Biol, Cambridge, MA 02142 USA
关键词
tumor; carcinoma; breast; paracrine; epithelial; fibroblast; myofibroblast; stroma; desmoplasia;
D O I
10.1006/excr.2000.5133
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumors arise from cells that have sustained genetic mutations resulting in deregulation of several of their normal growth-controlling mechanisms. Much of the research concerning the origins of cancer has focused on the genetic mutations within tumor cells, treating tumorigenesis as a cell-autonomous process governed by the genes carried by the tumor cells themselves. However, it is increasingly apparent that the stromal microenvironment in which the tumor cells develop profoundly influences many steps of tumor progression. In various experimental tumor models, the microenvironment affects the efficiency of tumor formation, the rate of tumor growth, the extent of invasiveness, and the ability of tumor cells to metastasize. In carcinomas, the influences of the microenvironment are mediated, in large part, by paracrine signaling between epithelial tumor cells and neighboring stromal fibroblasts, In this review, we summarize recent advances in understanding the paracrine signaling interactions between epithelial cancer cells and associated fibroblasts and examine the effects of these bidirectional interactions on various aspects of carcinoma formation. We note, however, that paracrine signaling between other cell types within the carcinomas, such as endothelial cells and inflammatory cells, may play equally important roles in tumor formation and we will refer to these heterotypic interactions where relevant. (C) 2001 Academic Press.
引用
收藏
页码:169 / 184
页数:16
相关论文
共 141 条
  • [1] Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
  • [2] 2-Z
  • [3] ANTI-TRANSFORMING GROWTH-FACTOR (TGF)-BETA ANTIBODIES INHIBIT BREAST-CANCER CELL TUMORIGENICITY AND INCREASE MOUSE SPLEEN NATURAL-KILLER-CELL ACTIVITY - IMPLICATIONS FOR A POSSIBLE ROLE OF TUMOR-CELL HOST TGF-BETA INTERACTIONS IN HUMAN BREAST-CANCER PROGRESSION
    ARTEAGA, CL
    HURD, SD
    WINNIER, AR
    JOHNSON, MD
    FENDLY, BM
    FORBES, JT
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2569 - 2576
  • [4] Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254
  • [5] BARSKY SH, 1987, CANCER RES, V47, P1663
  • [6] A NOVEL METALLOPROTEINASE GENE SPECIFICALLY EXPRESSED IN STROMAL CELLS OF BREAST CARCINOMAS
    BASSET, P
    BELLOCQ, JP
    WOLF, C
    STOLL, I
    HUTIN, P
    LIMACHER, JM
    PODHAJCER, OL
    CHENARD, MP
    RIO, MC
    CHAMBON, P
    [J]. NATURE, 1990, 348 (6303) : 699 - 704
  • [7] BASSET P, 1994, CANCER-AM CANCER SOC, V74, P1045, DOI 10.1002/1097-0142(19940801)74:3+<1045::AID-CNCR2820741511>3.0.CO
  • [8] 2-7
  • [9] Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
    Bergers, G
    Brekken, R
    McMahon, G
    Vu, TH
    Itoh, T
    Tamaki, K
    Tanzawa, K
    Thorpe, P
    Itohara, S
    Werb, Z
    Hanahan, D
    [J]. NATURE CELL BIOLOGY, 2000, 2 (10) : 737 - 744
  • [10] Mechanisms of disease:: Role of transforming growth factor β in human disease.
    Blobe, GC
    Schiemann, WP
    Lodish, HF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) : 1350 - 1358